Search

everythinglearnresearchcommunity

for

Search:↓

Certain small molecules can help regrow hair by turning on the body's cell cleanup process.

Certain small molecules that trigger cell cleanup processes can promote hair growth.

Women also use 5α-reductase inhibitors, and their effects differ from men.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

El Síndrome de Ovario Poliquístico causa problemas de piel como acné y es importante reconocerlo temprano para tratarlo.

A woman had temporary hair loss due to stress from a spinal cord injury.

Understanding skin patterns can help us learn about skin diseases and their treatments.

Female pattern hair loss is caused by genetics and hormones, leading to hair thinning in women.

Hair loss can be linked to hormonal changes, and physical conditions like heart defects can cause depression.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Alopecia areata patients may have higher T3 and cortisol levels, suggesting a hormonal link.

Androgenetic alopecia is linked to aging due to inflammation, oxidative stress, and hormonal changes.